Rod mediated dark adaptation, a functional test for early and intermediate AMD outcomes

Click to increase image sizeClick to decrease image size

Declaration of interest

CA Curcio receives research funds from Genentech/Hoffman LaRoche and Regeneron and consults for Apellis, Astellas, Boehringer Ingelheim, Character Biosciences, Osanni, and Annexon (outside this project). C. Owsley is an inventor of the method and apparatus for the detection of impaired dark adaptation used in our research. She consults for Johnson & Johnson Vision (outside this project). D. Kar is currently an employee of Apellis Pharmaceuticals.

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

R01EY029595 (CO, CAC) and R01EY027948 (CAC); P30EY03039 (CO); Dorsett Davis Discovery Fund (CO), and Alfreda J. Schueler Trust (CO); Unrestricted funds to the Department of Ophthalmology and Visual Sciences (UAB) from Research to Prevent Blindness, Inc., and EyeSight Foundation of Alabama.